JP3435000009 (JP3435000009)

$19.12T
Market Cap
15.6
P/E Ratio
0.70
Beta
0.77%
Dividend Yield
Piotroski 8/9Altman Z 1.1 DistressBeneish M -2.79 CleanROIC−WACC -3.8%

Quantitative Summary

Deterministic

Strong operational fundamentals (Piotroski 8/9) with Altman Z of 1.1.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency presents a stark contradiction to the company's financial stability indicators. While the Piotroski F-Score of 8/9 and Beneish M-Score of -2.79 signal robust fundamental health with minimal earnings manipulation risk, the DuPont decomposition reveals significant structural weakness: an ROIC-WACC spread of -3.8% indicates that capital deployment is actively destroying value relative to the cost of financing. This negative spread persists despite healthy operating leverage, evidenced by a net margin of 8.8% and gross margin of 28.3%, suggesting that low asset turnover or excessive financial leverage are suppressing returns on invested capital rather than pricing pressures eroding profitability margins.

Valuation metrics further complicate the investment thesis by diverging from intrinsic value estimates derived from discounted cash flow analysis. The current trading multiple of 15.6x sits at a discount to the DCF-implied fair value of $3,580 per share, yet this apparent undervaluation is counterbalanced by stagnant top-line performance with revenue growth contracting slightly year-over-year at -0.5%. Market pricing appears to be heavily weighted toward downside risks inherent in the negative ROIC-WACC spread and weak revenue trajectory, potentially discounting future recovery potential that the DCF model assumes will materialize. The discrepancy between the low P/E multiple and high fair value target suggests the market may be over-penalizing current operational inefficiencies while underestimating long-term cash flow generation capabilities if margin expansion or asset turnover improves.

The Altman Z-Score of 1.1 places the entity in a precarious zone regarding bankruptcy risk, introducing substantial downside volatility that offsets the high-quality score on earnings stability metrics. This financial distress signal necessitates extreme caution when interpreting the Piotroski F-Score's positive attributes, as liquidity constraints could force distressed asset sales or aggressive deleveraging that further compresses ROIC. Consequently, the risk-reward profile is skewed heavily toward capital preservation rather than growth participation, with the negative spread acting as a persistent drag on shareholder returns until underlying operational mechanics reverse course to generate value-creating investments.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6.7%8.7%10.7%
2%$4424$3185$2514
3%$5357$3580$2723
4%$6979$4142$2994

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.7%, terminal growth 3%. Fair value $3580 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
1.1
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.79
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

28.3%
Gross Margin
8.8%
Net Margin
4.9%
ROIC
8.7%
WACC
ROIC − WACC Spread: -3.8%— Negative spread.
-0.5%
Revenue Growth (YoY)
+17.6%
Earnings Growth (YoY)
1.7T
Free Cash Flow
7%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

3.15x
Debt / Equity
0.70x
Current Ratio
37.1x
Interest Coverage
-0.3x
Net Debt / EBITDA
9.20%
FCF Yield
2.7T
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $24.95
Act: $32.88
+31.8%
Q3
✓ Beat
Est: $35.87
Act: $39.40
+9.8%
Q2
✓ Beat
Est: $51.51
Act: $60.43
+17.3%
Q1
✓ Beat
Est: $59.92
Act: $62.82
+4.8%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

17.6
Forward P/E
PEG Ratio
2.35
Price/Book
22M
Avg Volume
$4776.00
52W High
$2980.50
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$1.9B
Tracked Passive Exposure
6
ETFs Holding JP3435000009
0.48%
Avg Weight in ETFs
$385B
Total ETF AUM

When investors buy or sell ETFs like EFA or IEFA, the fund manager is mechanically forced to buy or sell JP3435000009 shares regardless of JP3435000009's individual fundamentals. We estimate $1.9B of passive capital is structurally linked to JP3435000009 through 6 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in JP3435000009 to visualize passive redemption contagion across ETFs and collateral stocks.

JP3435000009 Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
JP3435000009EpicenterIEFAETFEFAETFSCHFETFNL0010273215Low RiskCH0012032048Low RiskNVDALow RiskCH0012005267Low RiskAAPLLow Risk
JP3435000009 Price Drop (%)0

If JP3435000009 (JP3435000009) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 3 ETFs with JP3435000009. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

JP3435000009 Ownership Dynamics

Ticker
JP3435000009

Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

JP3435000009 Capital Efficiency

How efficiently does JP3435000009 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$1674.1B
EBITDA
$2667.6B
FCF Conversion
63%
Reinvestment Rate
37%
63% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
4.9%
ROIC − WACC Spread
-3.8%

JP3435000009 converts 63% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-3.8%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare JP3435000009 to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.